Shares of Dentsply Sirona Inc. (XRAY) experienced a massive selloff on Wednesday, plummeting more than 21% in pre-market trading. The steep decline came after the dental products giant slashed its full-year revenue and earnings guidance for 2024, citing several headwinds and market pressures.
While Dentsply Sirona reported better-than-expected third-quarter earnings of $0.50 per share, beating analysts' estimates of $0.47, the company's revised outlook for the full fiscal year overshadowed the positive earnings surprise. The company now expects net sales in the range of $3.79 billion to $3.83 billion, down from its previous guidance of $3.86 billion to $3.90 billion.
Additionally, Dentsply Sirona cut its adjusted earnings per share forecast to $1.82 to $1.86, compared to the earlier range of $1.96 to $2.02. The company cited market pressures impacting its U.S. equipment business, legislative changes affecting the direct-to-consumer aligner business model, and the voluntary suspension of sales, marketing, and shipments of Byte Aligners and Impression Kits as key factors contributing to the revised lower guidance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.